Patients with acute promyelocytic leukemia who underwent front-line treatment with all-trans–retinoic acid plus arsenic trioxide demonstrated improved health-related quality of life after induction ...

Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era Event-free survival following ...

Please provide your email address to receive an email when new articles are posted on . All-trans-retinoic acid and arsenic trioxide induced stronger and more sustained antileukemic activity than ...

A new combination of therapies has been shown to be effective in the treatment of acute promyelocytic leukemia (APL). A complete remission was achieved in all 77 (100%) patients in the ATRA-arsenic ...

The use of arsenic trioxide instead of idarubicin in combination with all-trans retinoic acid (ATRA) is a feasible option in patients with acute promyelocytic leukaemia, regardless of risk level, ...

Possible Future Issues in the Treatment of Glioblastomas: Special Emphasis on Cell Migration and the Resistance of Migrating Glioblastoma Cells to Apoptosis Arsenic trioxide has shown great promise in ...

Combining all-trans retinoic acid (ATRA) with arsenic trioxide (ATO) and idarubicin significantly improved event-free survival (EFS) compared with the standard treatment of ATRA and ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN DIEGO -- An ...

All-trans retinoic acid (ATRA) and chemotherapy are curative in patients with non–high-risk acute promyelocytic leukemia (APL) (white-cell count <10,000 per cubic millimeter). However, patients can ...

WINSTON-SALEM, N.C. – Thursday, Nov. 11, 2010 – Arsenic, a toxic compound with a reputation as a good tool for committing homicide, has a significant positive effect on the survival of patients with ...